Sort
48,018 grants matching “immunotherapy”
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,122,303Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Surgery Branch Cell Prep Core
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Cell Production Core Facility
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,121,375Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Control of Cytokine Gene Expression in LymphoidMyeloid Cells
$1,119,930Howard A Young · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Microparticle Therapy for Cerebral Amyloid Angiopathy
$1,119,539Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2021 · AG
Philadelphia Pediatric AIDS Clinical Trials Unit
$1,119,014Children'S Hospital Of Philadelphia · U01 · FY2002 · AI
Ann Arbor regional CCOP
$1,118,919Saint Joseph Mercy Health System · U10 · FY2004 · CA
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$1,118,405Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
$1,117,983Isabel Kurth · Rgenix, Inc. · R44 · FY2016 · CA
Innovations in Functional B Cell Epitope Discovery for Food Allergy
$1,117,972Scott Boyd · Stanford University · N01 · FY2025 · AI
Immunobiology and immunotherapy of leukemia
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Characterization and improvement of graft versus leukemia effects
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,117,743Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2011 · AI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,117,537Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2024 · TR
Immune Function and the Progression to Type 1 Diabetes
$1,117,395Mark A Atkinson · University Of Florida · P01 · FY2011 · AI
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,117,358Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2020 · AI
Tumor Plasticity
$1,117,200Dario C. Altieri · Wistar Institute · R35 · FY2023 · CA
Tumor Plasticity
$1,117,200Dario C. Altieri · Wistar Institute · R35 · FY2022 · CA
Understanding the Role of the Host Response in HIVSIV Infection
$1,116,963Genoveffa Franchini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,116,963Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2024 · CA
Pediatric AIDS Clinical Trials Group
$1,116,567St. Jude Children'S Research Hospital · U01 · FY2003 · AI
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis
$1,116,420Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Adenosine Receptor Agonists as an Immunotherapy for Biodefense
$1,115,978Ian Justin Glomski · University Of Virginia · U01 · FY2010 · AI
Point-of-Care Microfluidics in Lung Cancer
$1,115,405Mehmet Toner · Massachusetts General Hospital · R01 · FY2008 · EB